Tag: Non-small-cell lung cancer

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Non-small-cell lung cancer

Final Analysis of CheckMate -816 Trial Shows Opdivo Plus Chemotherapy Boosts Overall ...

Added to Collection on: 2025-02-19 18:24:04

Tags for this article:

Antineoplastic drugs
Lung cancer
Orphan drugs
Nivolumab
Cancer treatments
Immune system
Non-small-cell lung cancer
Ipilimumab
Bristol-Myers Squibb
Small-cell carcinoma
Neoadjuvant therapy
Programmed cell death protein 1
Opdivo

Click the tags to see associated articles and topics

View Article Details
Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management - OncLive

Added to Collection on: 2025-02-21 21:19:48

Tags for this article:

Pyrazoles
Orphan drugs
Lung cancer
Tyrosine kinase receptors
Antineoplastic drugs
Lorlatinib
ALK inhibitor
Crizotinib
Anaplastic lymphoma kinase
Non-small-cell lung cancer
ALK positive lung cancer
ROS1
Alectinib

Click the tags to see associated articles and topics

View Article Details
Summit Incurs In-Line Q4 Loss, Inks Collaboration Deal With Pfizer - February 25, 2025

Added to Collection on: 2025-02-25 12:42:02

Tags for this article:

Antineoplastic drugs
Research and development in the United States
Lung cancer
Pfizer
Antibody-drug conjugate
Non-small-cell lung cancer
Pembrolizumab
Summit Therapeutics PLC

Click the tags to see associated articles and topics

View Article Details
Checkpoint Inhibitor Shows High Success Rate in Advanced Skin Cancer

Added to Collection on: 2025-03-05 16:51:03

Tags for this article:

Lung cancer
Cancer
Gynaecological cancer
Infectious causes of cancer
Cemiplimab
Cutaneous squamous-cell carcinoma
Checkpoint inhibitor
Non-small-cell lung cancer
Regeneron Pharmaceuticals
Skin cancer
Squamous-cell carcinoma
PD-1 and PD-L1 inhibitors
Regeneron
Libtayo

Click the tags to see associated articles and topics

View Article Details
Velcheti Evaluates Activity of Repotrectinib for ROS1 Fusion–Positive NSCLC

Added to Collection on: 2025-03-15 15:07:04

Tags for this article:

Tyrosine kinase receptors
Antineoplastic drugs
ROS1
Orphan drugs
Ethers
Amines
ALK inhibitor
Entrectinib
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Crizotinib
Gefitinib

Click the tags to see associated articles and topics

View Article Details
Potential Challenger For AstraZeneca's Blockbuster Lung Cancer Drug? - Benzinga

Added to Collection on: 2025-03-20 13:26:13

Tags for this article:

Lung cancer
Acrylamides
Indoles
Pyrimidines
Orphan drugs
Osimertinib
Epidermal growth factor receptor
AstraZeneca
Pharmaceutical industry in China
Non-small-cell lung cancer
Asandeutertinib
Afatinib
TYK Medicines Inc.

Click the tags to see associated articles and topics

View Article Details
Addition of Savolitinib Can Reverse Osimertinib Resistance in Advanced NSCLC

Added to Collection on: 2025-04-08 19:28:37

Tags for this article:

Lung cancer
Orphan drugs
Acrylamides
Ethers
Osimertinib
Pyrimidines
Non-small-cell lung cancer
Epidermal growth factor receptor
T790M
Myung-Ju Ahn

Click the tags to see associated articles and topics

View Article Details
Gilead's Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer

Added to Collection on: 2025-04-22 12:52:10

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Ivonescimab
Triple-negative breast cancer
Antibody-drug conjugate
Sacituzumab govitecan
Vascular endothelial growth factor
Pembrolizumab
Non-small-cell lung cancer
Programmed cell death protein 1
Bispecific monoclonal antibody
Merck
Gilead

Click the tags to see associated articles and topics

View Article Details
FDA Approves Akeso's PD-1 Monoclonal Antibody for Recurrent or Metastatic Non ...

Added to Collection on: 2025-04-25 16:13:08

Tags for this article:

Lung cancer
Infectious causes of cancer
Orphan drugs
Angiogenesis inhibitors
Antineoplastic drugs
Nasopharyngeal carcinoma
Non-small-cell lung cancer
Ivonescimab
Head and neck cancer
Small-cell carcinoma
Nivolumab
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details
Raffaele Colombo highlights FDA Breakthrough Device Designation for Roche's TROP2 ...

Added to Collection on: 2025-05-04 10:04:42

Tags for this article:

Antibody-drug conjugates
Datopotamab deruxtecan
Deruxtecan
Non-small-cell lung cancer
Stephen V Liu
Raffaele Colombo
Zymeworks
AstraZeneca
Roche Diagnostics

Click the tags to see associated articles and topics

View Article Details
Book a Demo